Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aidan Hollis

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Pharmacoeconomics|June 3, 2016
Sustainable Financing of Innovative Therapies: A Review of ApproachesAidan Hollis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 23, 2002
The link between publicly funded health care and compulsory licensingAidan Hollis
Pharmacoeconomics|December 13, 2005
Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development"Aidan Hollis
Expert Opinion on Therapeutic Patents|October 5, 2017
Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles?Aidan Hollis
Healthcare Policy = Politiques De Sante|October 21, 2019
Orphan Drug Pricing and Costs: A Case Study of Kalydeco and OrkambiAidan Hollis
Healthcarepapers|January 9, 2010
Notes on value for money in healthcareAidan Hollis
Health Economics|November 29, 2002
The importance of being first: evidence from Canadian generic pharmaceuticalsAidan Hollis
Systems and Synthetic Biology|January 17, 2014
Synthetic biology: ensuring the greatest global valueAidan Hollis
Healthcarepapers|January 24, 2023
High Prices for High Profits?Aidan Hollis
Applied Health Economics and Health Policy|December 22, 2023
An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for EveryoneAidan Hollis
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|June 3, 2016
Sustainable Financing of Innovative Therapies: A Review of ApproachesAidan Hollis
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 23, 2002
The link between publicly funded health care and compulsory licensingAidan Hollis
Pharmacoeconomics|December 13, 2005
Comment on "The economics of follow-on drug research and development: trends in entry rates and the timing of development"Aidan Hollis
Expert Opinion on Therapeutic Patents|October 5, 2017
Bill C-30: who wins and who loses in Canada's pharmaceutical patent battles?Aidan Hollis
Healthcare Policy = Politiques De Sante|October 21, 2019
Orphan Drug Pricing and Costs: A Case Study of Kalydeco and OrkambiAidan Hollis
Healthcarepapers|January 9, 2010
Notes on value for money in healthcareAidan Hollis
Health Economics|November 29, 2002
The importance of being first: evidence from Canadian generic pharmaceuticalsAidan Hollis
Systems and Synthetic Biology|January 17, 2014
Synthetic biology: ensuring the greatest global valueAidan Hollis
Healthcarepapers|January 24, 2023
High Prices for High Profits?Aidan Hollis
Applied Health Economics and Health Policy|December 22, 2023
An Optional Delinked Reward System: Making Pharmaceutical Innovation Work for EveryoneAidan Hollis
Pageof 7